Marie Decraecker
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 03, 2026
Management of rare primary liver cancers: combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: April 30, 2026
From Theory to Practice: Which Biomarkers Are Ready for Predicting Response in Advanced HCC?
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 13, 2026
Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS).
Journal: Journal of liver cancer
Published: January 16, 2026
Primary Tumor-Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer.
Journal: Genes, chromosomes & cancer
Published: December 09, 2025
Impact of Child Pugh B Stage for the Treatment of Advanced HCC.
Journal: Journal of hepatocellular carcinoma
Published: November 06, 2025
Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort.
Journal: JHEP reports : innovation in hepatology
Published: October 20, 2025
Response to letter Re: Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 16, 2025
Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group.
Journal: Clinics and research in hepatology and gastroenterology
Published: September 16, 2025
Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study.
Journal: Journal for immunotherapy of cancer
Published: September 14, 2025
Benefit and safety of capecitabine after resection of biliary tract cancer: a real-world study with propensity score matching.
Journal: Frontiers in oncology
Published: September 02, 2025
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: July 28, 2025
Last Updated: 09/26/2026